<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8918110</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2607</journal-id>
<journal-id journal-id-type="nlm-ta">Eur J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Neurosci.</journal-id>
<journal-title-group>
<journal-title>The European journal of neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0953-816X</issn>
<issn pub-type="epub">1460-9568</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28700108</article-id>
<article-id pub-id-type="pmc">5562924</article-id>
<article-id pub-id-type="doi">10.1111/ejn.13646</article-id>
<article-id pub-id-type="manuscript">NIHMS891925</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GPR88 in A<sub>2A</sub>receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Meirsman</surname>
<given-names>A.C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Kerchove d’Exaerde</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kieffer</surname>
<given-names>B.L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ouagazzal</surname>
<given-names>A.M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Département de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM U-964, CNRS UMR-7104, Université de Strasbourg, Illkirch, France</aff>
<aff id="A2">
<label>2</label>Neuroscience Paris Seine, Institut de Biologie Paris Seine, CNRS UMR 8246/INSERM U1130/Université Pierre et Marie Currie, 9 Quai Saint Bernard, F-75005, Paris France</aff>
<aff id="A3">
<label>3</label>Laboratory of Neurophysiology, Université Libre de Bruxelles, ULB Neuroscience Institute, Belgium</aff>
<aff id="A4">
<label>4</label>Douglas Research Center, Departement of Psychiatry, McGill University, Montréal Canada</aff>
<aff id="A5">
<label>5</label>Laboratoire de Neurosciences Cognitives, AMU-CNRS UMR-7291, Aix-Marseille Université, Marseille, France</aff>
<author-notes>
<corresp id="FN1">Corresponding author: B. L. Kieffer, Département de Neurobiologie et Génétique, Institut de Biologie Moléculaire et Cellulaire, 1 rue Laurent Fries, 67 404 Illkirch Cedex, France and Douglas Hospital Research Center, Department of Psychiatry, Faculty of Medicine, McGill University, Montreal (Quebec), Canada. <email>Brigitte.Kieffer@douglas.mcgill.ca</email>, Phone: 514 761-6131 ext.: 3175; fax: 514 762-3033</corresp>
<fn id="FN2">
<p>PROF. BRIGITTE L KIEFFER (Orcid ID : 0000-0002-4107-9064)</p>
</fn>
<fn fn-type="COI-statement" id="FN4">
<p>
<bold>Disclosure/conflict of interest</bold>
</p>
<p>The authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>46</volume>
<issue>4</issue>
<fpage>2026</fpage>
<lpage>2034</lpage>
<!--elocation-id from pubmed: 10.1111/ejn.13646-->
<abstract>
<p id="P1">The orphan receptor, GPR88, is emerging as a key player in the pathophysiology of several neuropsychiatric diseases, including psychotic disorders. Knockout (KO) mice lacking GPR88 throughout the brain exhibit many abnormalities relevant to schizophrenia including locomotor hyperactivity, behavioral hypersensitivity to dopaminergic psychostimulants and deficient sensorimotor gating. Here, we used conditional knockout (cKO) mice lacking GPR88 selectively in striatal medium spiny neurons expressing A<sub>2A</sub>receptor to determine neuronal circuits underlying these phenotypes. We first studied locomotor responses of A<sub>2A</sub>R<italic>-Gpr88</italic> KO mice and their control littermates to psychotomimetic, amphetamine, and to selective D1 and D2 receptor agonists, SKF-81297 and quinpirole, respectively. To assess sensorimotor gating performance, mice were submitted to acoustic and visual prepulse inhibition (PPI) paradigms. Total knockout GPR88 mice were also studied for comparison. Like total GPR88 KO mice, A<sub>2A</sub>R<italic>-Gpr88</italic> KO mice displayed a heighted sensitivity to locomotor stimulant effects of amphetamine and SKF-81297. They also exhibited enhanced locomotor activity to quinpirole, which tended to suppress locomotion in control mice. By contrast, they had normal acoustic and visual PPI, unlike total GPR88 KO mice that show impairments across different sensory modalities. Finally, none of the genetic manipulations altered central auditory temporal processing assessed by gap-PPI. Together these findings support the role of GPR88 in the pathophysiology of schizophrenia and show that GPR88 in A<sub>2A</sub>receptor expressing neurons modulates psychomotor behavior but not sensorimotor gating.</p>
</abstract>
<kwd-group>
<kwd>Cross-modal PPI</kwd>
<kwd>schizophrenia</kwd>
<kwd>D2R-medium spiny neurons</kwd>
<kwd>GAP detection</kwd>
<kwd>striatum</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>